Home / Learn / Dosage Guide

Kratom Dosage Guide

Updated May 3, 2026

Medically reviewed

Reviewed for clinical accuracy and dosing-safety considerations by Brian Trappler, MD — Board-Certified Psychiatrist (ABPN), Associate Professor in Clinical Psychiatry (retired), SUNY Downstate Medical Center. Last reviewed: May 3, 2026.

Kratom has no FDA-approved dosage guidelines. What exists is a consistent body of survey data, pharmacokinetic research, and community experience that points to clear patterns: most people find 2–5g of plain leaf powder to be the effective range, with effects shifting from stimulant-dominant below 3g to sedation/analgesia-dominant above 5g. The single most important principle is starting lower than you think you need to and adjusting upward incrementally — never within the same session.

What Is the Right Dose by Experience Level?

Experience level is the most reliable starting predictor of appropriate dose — more so than body weight or other individual factors — because tolerance from prior use is the dominant variable. Grundmann (2017) surveyed 8,049 kratom users in the United States and documented a median single dose of approximately 4–5g of powder among regular users, with substantial variation based on usage history and intent.[1] Smith et al. (2022) confirmed dose-dependent effect patterns in a separate sample, with stimulant effects predominant at lower doses and sedative/analgesic effects predominant above 5g.[2]

Kratom Dosage by Experience Level — Plain Leaf Powder
Experience Level Starting Dose Typical Range Dominant Effects
First-time / Beginner 1.5 g 1.5–2.5 g Mild alertness, subtle mood lift; threshold effects only
Low Tolerance 2 g 2–3.5 g Clear stimulant effects; mood elevation; manageable duration
Regular User 3 g 3–5 g Full effects — stimulant (white/green) or relaxation (red); 4–6 hr window
High Tolerance 5 g 5–7 g Opioid-dominant: sedation, analgesia; higher side effect risk

Grundmann (2017) also found that most adverse effects reported by survey respondents were associated with higher doses — reinforcing the value of the minimum effective dose principle across all experience levels.[1]

The critical first-session rule: Take your dose, then wait the full onset window — 45 minutes for powder on an empty stomach, up to 60 minutes for capsules. Do not re-dose because effects feel mild during the rising phase (45 min–1.5 hr). The second dose arrives on top of the first at peak, producing double the intended dose. This is the most common cause of unintended adverse effects in new users.

Digital scale measuring kratom powder showing accurate gram measurement for dosing
A digital scale accurate to 0.1g is the single most important piece of equipment for consistent kratom dosing. Teaspoon estimates are unreliable — kratom powder density varies significantly between vendors and grind styles.

How Does Kratom Form Affect Dosing?

Different kratom formats are not gram-equivalent in potency. Extracts concentrate alkaloids, so a gram of extract is not a gram of plain leaf. This is the most dangerous dosing misunderstanding in the kratom market — and the source of most extract-related adverse experiences.

Kratom Dosage by Format
Format Beginner Starting Dose Regular User Range Notes
Powder 1.5–2 g 3–5 g Weigh on a scale. A level teaspoon ≈ 2–2.5g but varies by grind — never rely on volume.
Capsules (0.5g each) 3–4 capsules (1.5–2g) 6–10 capsules (3–5g) Onset 30–60 min due to capsule dissolution. Wait the full hour before assessing.
Kratom Tea 2–3 g (leaf equivalent) 3–6 g (leaf equivalent) Alkaloid extraction ~70–85% of raw powder. Slightly higher gram weight may be needed for equivalent effect.
Extracts ½ the label minimum Follow COA mitragynine mg Not gram-equivalent to plain leaf. A 10x extract at 0.5g delivers ~5g equivalent alkaloid load. Do NOT start with extracts.
Shots ½ bottle ½–1 bottle Liquid extract — fast onset (10–25 min). Check the COA for mitragynine mg per bottle to compare to your powder dose.
Gummies 1 gummy 1–2 gummies Pre-dosed extract edibles. Follow package serving; individual gummies vary 10–50mg mitragynine each.

Onset timing also differs meaningfully by format. Trakulsrichai et al. established the pharmacokinetic baseline for oral mitragynine — Tmax (time to peak plasma) of ~1.5 hours for standard powder; capsules push this later due to shell dissolution time.[3] The only way to compare dosing across formats accurately is by milligrams of mitragynine — not grams of product. A COA that discloses mitragynine percentage or mg per unit is the only tool that lets you do this comparison. Without it, you’re guessing. See our Kratom COA Guide for how to read a lab report and find the mitragynine number.

How Does Vein Color Affect Dosing?

Vein color influences how strongly effects are felt at a given dose — not because different colors are inherently “stronger,” but because different alkaloid ratios affect where in the dose-response curve specific effects appear.

  • Red vein — tends to produce noticeable relaxation and analgesic effects at slightly lower doses than green or white vein. Experienced users frequently report reds feeling “heavier” per gram. If starting with red vein, stay at the lower end of your experience bracket (1–2g for beginners; 3–4g for regular users).
  • Green vein — the most balanced profile. Stimulant effects at low dose, relaxation at moderate dose. Most forgiving starting strain. Dose range matches the experience level table above closely.
  • White vein — stimulant-dominant. Some users find they need slightly more white vein to achieve relaxation compared to red, because the adrenergic effects mask the opioid-receptor effects at the same gram weight. For stimulant purposes, white vein at 2–3g is typically sufficient without going higher.
  • Yellow/Gold — typically processed variants; alkaloid profile varies more than standard veins. Start low and adjust; the processing method has more effect on the dose-response than the original vein color.

Any new strain — even within a vein color you’ve used before — should be treated as a new product requiring fresh calibration. Alkaloid percentage varies between batches and vendors — Smith et al. (2022) identified this product-to-product alkaloid variation as a significant confounding factor in dose-effect research.[2] Starting 20–25% lower than your normal dose with a new strain or new vendor is a reliable harm-reduction practice.

What Factors Affect How Much You Need?

  • Mitragynine percentage of the product — The most important variable most users ignore. A 4g dose of 1.2% mitragynine powder delivers 48mg mitragynine; the same 4g of 1.7% delivers 68mg — a 42% difference in actual alkaloid load. This variation explains why the same gram dose can feel very different between vendors. COA-verified percentage is the only objective way to normalize dosing across products.
  • Stomach contents — Fasted state (empty stomach, 2+ hours since eating) produces faster onset (15–30 min for powder) and higher peak plasma concentration. A large meal reduces peak concentration substantially — 40–60% reduction in effective Cmax is plausible. Light snack beforehand is the best balance of speed and reduced nausea risk.
  • Individual CYP enzyme status — Mitragynine is metabolized primarily by CYP3A4 and CYP2D6. Trakulsrichai et al. (2015) established the pharmacokinetics in human subjects, documenting a mean elimination half-life of approximately 9 hours — but individual variation is significant.[3] Tanna et al. (2022) in Pharmaceutics extended that picture with a controlled clinical pharmacokinetic assessment of kratom tea in healthy adults, confirming multi-compartmental disposition for mitragynine and meaningful inter-subject variability in Cmax, AUC, and 7-HMG generation at the same weighed alkaloid dose.[4] Fast metabolizers may require higher doses or more frequent dosing; slow metabolizers may find standard doses produce prolonged, stronger effects.
  • Body weight — Less predictive than commonly assumed. Mitragynine has a high volume of distribution (does not stay confined to blood volume), making simple weight-based dosing formulas unreliable. Treat it as one factor among several rather than the primary dosing guide.
  • Hydration — Dehydration impairs alkaloid distribution and can intensify side effects. Drink adequate water when using kratom.
  • Concurrent medications — CYP3A4 and CYP2D6 inhibitors (grapefruit juice, certain antidepressants, antifungals) can elevate mitragynine plasma levels significantly. Any prescription drug should be checked for CYP3A4 interaction before combining with kratom.

How Do You Measure Kratom Accurately?

A digital kitchen scale accurate to 0.1g is required for precise kratom dosing — not optional, not a nice-to-have. Here is why volumetric measuring fails:

  • A level teaspoon of kratom powder can range from 1.8g to 3.2g depending on the grind fineness and how tightly packed it is
  • Different vendors produce powders of different densities — the same volume means different weights
  • A 1g error at a 2g starting dose is a 50% dosing error — clinically significant

The Grundmann (2017) survey found significant dose variation across respondents that was not fully explained by weight or tolerance — product-level alkaloid inconsistency and volumetric measuring errors are the most plausible explanations.[1] A $10–15 digital scale eliminates this variable entirely. Place a small cup or piece of paper on the scale, tare to zero, then spoon your kratom in until you reach your target weight. This takes 30 seconds and removes the single largest source of inconsistency in kratom self-administration.

Capsule counting: If using pre-filled capsules, verify the capsule weight from the vendor’s COA or product description. Most standard kratom capsules are 0.5g each; some are 0.7g or 1g. Counting capsules without knowing the fill weight is the same error as eyeballing powder.

How Does Tolerance Change Your Dose Over Time?

Tolerance is the most commonly cited reason people escalate kratom doses — and the escalation trap is the primary driver of problematic use. The mechanism: daily kratom use downregulates mu-opioid receptors, reducing receptor density and sensitivity. The same dose produces weaker effects, so the user increases the dose. The increased dose drives more receptor downregulation. The cycle produces progressively higher doses with progressively less satisfaction — until users are taking 7–10g daily and wondering why it’s not working. Smith et al. (2022) documented this escalation pattern in self-reported dose histories.[2] Rogers et al. (2024) in Drug and Alcohol Dependence sharpened that picture by applying DSM-5 substance-use-disorder criteria to a US kratom-user sample and finding that dosing amount (grams per day) — not just dosing frequency — was the stronger predictor of meeting physical-dependence criteria.[5] Practically: the escalation itself, more than how many times a day you dose, is what shifts a user from managing tolerance into managing dependence.

Smith et al. (2024) added the other half of the picture with ecological momentary assessment across real-world kratom sessions, showing that time-to-onset and peak effect shift with product type and assayed alkaloid content — which is why a dose that worked at one vendor’s 1.3% mitragynine powder may feel different at another vendor’s 1.7% even at the same gram weight.[6]

Signs you have a tolerance problem, not a dosing problem:

  • Your effective dose has doubled or tripled over the past 6–12 months
  • Effects feel flat even at your highest doses
  • You feel uncomfortable, irritable, or fatigued between doses (inter-dose symptoms)
  • You need kratom to feel “normal” rather than to achieve a specific benefit

The correct response to tolerance is not dose escalation — it is dose reduction and receptor reset through a tolerance break. A 5–14 day break can restore substantial receptor sensitivity, allowing effective dosing at a lower gram weight. See our Kratom Tolerance Break Guide for the break protocol and what to expect.

Strain rotation — alternating between different vein colors across sessions rather than using the same product every day — is the most practical tolerance-management strategy for regular users who do not want to take full breaks.

Chart showing kratom dose escalation over time with tolerance development versus stable dosing with rotation
Dose escalation driven by tolerance is the most common pattern that leads to problematic kratom use. Maintaining the minimum effective dose through rotation and periodic breaks keeps the dose stable long-term.

Frequently Asked Questions

How many grams of kratom should a beginner take?

Start with 1.5g. That is deliberately conservative — if you feel nothing, that information is useful. You can try 2.5g on the next session. You cannot undo a dose that was too high. First-time users have zero tolerance, meaning even a moderate dose can be uncomfortably strong. The risk of too little on the first session is mild disappointment; the risk of too much is nausea, dizziness, and a negative experience that may put you off a product that might otherwise have been helpful at a lower amount.

How many kratom capsules should I take?

Depends on the capsule fill weight. Most standard kratom capsules are 0.5g each. At 0.5g per capsule: beginners should start with 3–4 capsules (1.5–2g); regular users typically use 6–10 capsules (3–5g). Confirm the capsule fill weight from your vendor’s product page or COA before counting. Capsule onset is 30–60 minutes due to capsule dissolution — always wait the full hour before assessing.

Is 5 grams of kratom too much?

For a beginner with no tolerance, yes — 5g is likely to produce strong sedative effects and significant nausea risk. For a regular user with established tolerance, 5g is in the middle of the normal effective range. For a daily user who has been taking 7–8g, 5g may feel insufficient even though it is objectively not a low dose. “Too much” is relative to individual tolerance, not an absolute number.

What is the maximum safe kratom dose?

There is no established clinical maximum. The dose at which adverse effects become likely increases substantially above 8g — nausea, severe dizziness, and impaired cognition become very common above this level. Deaths attributed to kratom alone (without other substances) are exceptionally rare and involve disputed circumstances. The practical “ceiling” for most users is the dose above which side effects clearly outweigh desired effects — which varies individually but is typically in the 6–8g range. Doses above 10g are difficult to justify in terms of risk-benefit.

Why does the same amount of kratom feel different each time?

Most likely causes: stomach contents at time of dosing (biggest single variable for same-day variation); mitragynine percentage variation between batches of the same product; hydration level; tolerance shift from recent use frequency; or CYP enzyme competition from other substances or medications. Controlling stomach contents (consistent timing relative to meals) is the most practical way to improve dose-to-dose consistency.

How do I convert from powder to extract dosing?

Use milligrams of mitragynine as the common unit. If you take 4g of powder at 1.5% mitragynine, your effective dose is ~60mg mitragynine. If an extract shot contains 60mg mitragynine per bottle, that shot is equivalent — but its onset will be faster and its duration may differ. Check the COA of each product for the mitragynine mg per serving. Without this number, you cannot make a safe conversion.

Should I take more kratom if it stops working?

Generally no — if kratom has stopped working at your current dose, the cause is tolerance (receptor downregulation), not an insufficient dose. Adding more grams stimulates the same downregulated receptors, drives more tolerance, and reduces effectiveness further. The right answer is a tolerance break of 5–14 days to allow receptor upregulation. After a break, users consistently report that their previous effective dose works again — sometimes at half the amount they were taking before the break.

References

  1. Grundmann O. (2017). Patterns of kratom use and health impact in the US — results from an online survey. Drug and Alcohol Dependence. [PubMed]
  2. Smith KE, Feldman AZ, Rogers JM et al. (2022). Searching for a signal: self-reported kratom dose-effect relationships among a sample of US adults with regular kratom use histories. Drug and Alcohol Dependence. [PubMed]
  3. Trakulsrichai S, Sathirakul K, Auparppong S et al. (2015). Pharmacokinetics of mitragynine in man. Drug Design, Development and Therapy. [PubMed]
  4. Tanna RS, Nguyen JT, Hadi DL et al. (2022). Clinical pharmacokinetic assessment of kratom (Mitragyna speciosa), a botanical product with opioid-like effects, in healthy adult participants. Pharmaceutics. [PubMed]
  5. Rogers JM, Smith KE, Strickland JC, Epstein DH. (2024). Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: insights from dosing amount versus frequency. Drug and Alcohol Dependence. [PubMed]
  6. Smith KE, Panlilio LV, Feldman JD et al. (2024). Time course of kratom effects via ecological momentary assessment, by product type, dose amount, and assayed alkaloid content. Drug and Alcohol Dependence. [PubMed]

Disclaimer: This article is for educational purposes only and is not medical advice. Kratom is not FDA-approved to diagnose, treat, cure, or prevent any condition. Individual experiences vary. Consult a qualified healthcare provider before use, particularly if you take prescription medications or have underlying health conditions.

← Back to Learning Center

Brian Kan — Founder, Amazing Botanicals
About the Author
Brian Kan
Founder, Amazing Botanicals — 10+ Years in the Kratom Industry

Brian has built Amazing Botanicals from the ground up over the past decade, overseeing sourcing, independent lab testing, and quality control across 132 products and more than 225,000 customer orders. He holds AKA GMP qualification and writes on kratom science, safety, and responsible use.

← Back to Learning Center

Shop Lab-Tested Kratom

Browse our full selection of AKA GMP-qualified kratom — powder, capsules, extracts, and more. Free shipping on orders $99+.


Shop All Kratom
Disclaimer: This content is for educational purposes only and is not intended as medical, legal, or professional advice. Kratom is not approved by the FDA to diagnose, treat, cure, or prevent any disease.
Your Cart (0)

Your cart is empty

Browse Products